基于18F-FDG PET/CT线性回归斜率的异质性指数作为预测胰腺导管腺癌肿瘤复发的预后标志物
本研究回顾性纳入93例胰腺导管腺癌患者,评估术前18F-FDG PET/CT的异质性指数(线性回归斜率)对术后复发的预测价值。多因素Cox回归显示MTV(P=0.005)、TLG(P=0.004)和异质性指数-2(P=0.016)联合静脉侵犯均为显著预测因素。结论认为该异质性指数可作为术后复发的有效预测指标。
要点
- 93例胰腺导管腺癌患者中70例(75.3%)术后复发,平均复发时间9.4±8.4个月。
- 多因素Cox回归中MTV(P=0.005)、TLG(P=0.004)和异质性指数-2(P=0.016)均为显著预测因素。
- 异质性指数-2由MTV在SUV阈值2.0、2.5、3.0下的线性回归斜率计算得出。
核心结论
- 基于线性回归斜率的异质性指数可能成为胰腺癌术后复发的有效预测指标,与18F-FDG PET/CT体积参数及临床病理参数联合应用。
研究设计与样本
- 回顾性纳入93例胰腺导管腺癌患者(男:女=60:33,平均年龄64.2±9.1岁),术前接受18F-FDG PET/CT检查并接受胰腺手术。
主要发现
- 70例(75.3%)术后复发,平均复发时间9.4±8.4个月。
- 单因素Cox回归中MTV(P=0.013)、TLG(P=0.007)和异质性指数-2(P=0.027)显著;CA19-9(P=0.025)和静脉侵犯(P=0.002)亦显著。
- 多因素Cox回归中MTV(P=0.005)、TLG(P=0.004)和异质性指数-2(P=0.016)与静脉侵犯(P分别<0.001、0.001、0.001)均显著。
关键数值与推荐
- 异质性指数-1为变异系数(SUVmean除以标准差);异质性指数-2为MTV在SUV阈值2.0、2.5、3.0下的线性回归斜率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) has been investigated as a method to predict pancreatic cancer recurrence after pancreatic surgery. We evaluated the recently introduced heterogeneity indices of 18F-FDG PET/CT used for predicting pancreatic cancer recurrence after surgery and compared them with current clinicopathologic and 18F-FDG PET/CT parameters. METHODS: A total of 93 pancreatic ductal adenocarcinoma patients (M:F = 60:33, mean age = 64.2 ± 9.1 years) who underwent preoperative 18F-FDG PET/CT following pancreatic surgery were retrospectively enrolled. The standardized uptake values (SUVs) and tumor-to-background ratios (TBR) were measured on each 18F-FDG PET/CT, as metabolic parameters. Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were examined as volumetric parameters. The coefficient of variance (heterogeneity index-1; SUVmean divided by the standard deviation) and linear regression slopes (heterogeneity index-2) of the MTV, according to SUV thresholds of 2.0, 2.5 and 3.0, were evaluated as heterogeneity indices. Predictive values of clinicopathologic and 18F-FDG PET/CT parameters and heterogeneity indices were compared in terms of pancreatic cancer recurrence. RESULTS: Seventy patients (75.3%) showed recurrence after pancreatic cancer surgery (mean recurrence = 9.4 ± 8.4 months). Comparing the recurrence and no recurrence patients, all of the 18F-FDG PET/CT parameters and heterogeneity indices demonstrated significant differences. In univariate Cox-regression analyses, MTV (P = 0.013), TLG (P = 0.007), and heterogeneity index-2 (P = 0.027) were significant. Among the clinicopathologic parameters, CA19-9 (P = 0.025) and venous invasion (P = 0.002) were selected as significant parameters. In multivariate Cox-regression analyses, MTV (P = 0.005), TLG (P = 0.004), and heterogeneity index-2 (P = 0.016) with venous invasion (P < 0.001, 0.001, and 0.001, respectively) demonstrated significant results. CONCLUSIONS: The heterogeneity index obtained using the linear regression slope, could be an effective predictor of pancreatic cancer recurrence after pancreatic cancer surgery, in addition to 18F-FDG PET/CT volumetric parameters and clinicopathologic parameters.
引用
- Kim YI, Kim YJ, Paeng JC, et al. Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma. Eur J Nucl Med Mol Imaging. 2017. PMID: 28634684. doi:10.1007/s00259-017-3755-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。